or
forgot password

    • cancer clinical trials in bristol, CT

    • Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Bristol Hospital
    Bristol, Connecticut 06011-0977
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Bristol Hospital
    Bristol, Connecticut 06011-0977
    Colorectal Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Connecticut Gastroenterology Institute
    Bristol, Connecticut 06010
    Crohn's Disease